I am an Associate Professor of Medicine at Harvard Medical School and a physician–scientist at Brigham and Women’s Hospital, where I serve as Director of the Kidney and Pancreas Transplant Program and Director of the Transplantation Research Center. My work spans basic, translational, and clinical transplantation, with a focus on immune regulation, biomarker development, and novel therapeutic strategies to improve long-term allograft survival.
As a practicing transplant physician, I remain deeply engaged in the care of patients and the day-to-day challenges faced by clinicians. This experience shapes my scientific and leadership priorities, and I strongly believe that innovation must ultimately support those delivering care at the bedside and translate into meaningful improvements in patient outcomes.
My research focuses on advancing transplant immunology through the development of noninvasive diagnostics and immune-monitoring platforms, including extracellular vesicle–based assays and novel approaches to alloimmune risk assessment. A defining aspect of my work has been the translation of discovery into clinical application. I have led efforts to develop and license diagnostic platforms and have been directly involved in founding companies aimed at bringing innovative technologies into clinical practice. Through these experiences, I have gained a practical understanding of the full translational pathway—from early discovery to industry partnership, regulatory strategy, and clinical implementation.
I have been an active member of the American Society of Transplantation (AST) since 2008 and have contributed extensively across its programs and initiatives. I currently serve as Chair of the AST Scientific Research Network (SCIENCE) Review Committee and previously served as Chair of the AST Research Network Scientific Review Committee. I have also participated in the Awards and Grants Committee, Educational Committee, Fellows Symposium, Transplant Community Summit, and the Future of Transplantation Organizing Committee.
I founded the “Outstanding Questions in Transplantation” Community of Practice, which has engaged more than 3,000 members and played an important role in fostering real-time collaboration and knowledge exchange, including during the COVID-19 pandemic. I have also contributed to patient-centered initiatives through my involvement in the AST Patient Summit Task Force.
Through my clinical, scientific, and organizational leadership, I am committed to advancing innovation, supporting clinicians, and improving outcomes for transplant patients.
Advertisements
